Mast Cell Activation in Phosgene Oxime-Induced Cutaneous Injury: Mechanisms and Therapeutic Implications

Abstract

Abstract: Phosgene oxime (CX) is a potent chemical warfare agent causing rapid skin penetration, immediate tissue injury, and systemic toxicity. While mast cells mediate neuroimmune and inflammatory responses, their specific role in CX-induced injury remains poorly defined. Evaluating whether mast cells exacerbate tissue destruction or facilitate repair is critical for developing medical countermeasures, as no approved antidotes currently exist. This review examines CX-induced cutaneous injury via mast cell-mediated histamine release and evaluates potential therapeutic strategies. A PubMed search was conducted using terms including “phosgene oxime,” “mast cells AND skin inflammation,” and “cutaneous injury.” Following a screening of 130 abstracts, 30 primary research articles published between 1915 and 2026 were selected. Included studies focused on cellular injury pathways and mechanistic evaluations using in vitro and in vivo models. The literature consistently associates CX exposure with rapid mast cell activation, triggering histamine release, pro-inflammatory cytokine signaling, and progressive tissue necrosis. Data suggest that inhibiting signaling pathways, such as BTK and SYK, correlates with reduced inflammatory activity and limited tissue damage. These findings indicate that mast cell activation is consistently associated with increased CX-induced tissue injury, suggesting that mast cell-targeted interventions are a viable therapeutic direction. Future research should prioritize controlled animal studies to support the development of standardized medical countermeasures. Motivation/purpose: The motivation for this research is the lack of effective medical treatments for phosgene oxime (CX) exposure, a highly toxic chemical warfare agent that causes rapid and severe skin and systemic injury. Despite its known ability to trigger immediate tissue damage, the biological mechanisms driving this injury are not fully understood, particularly the role of mast cells in the inflammatory response. - The purpose of the study is to investigate whether mast cell activation contributes to CX-induced cutaneous injury or whether it may play a protective role in tissue repair. Specifically, the research aims to: - Clarify how CX activates mast cells and triggers inflammatory pathways such as histamine and cytokine release - Evaluate the involvement of signaling pathways like BTK and SYK in mediating tissue damage - Determine whether inhibiting mast cell activity can reduce inflammation and limit skin necrosis - Identify potential therapeutic targets for developing medical countermeasures against CX exposure - Overall, the study seeks to fill a critical gap in understanding CX toxicity and support the development of targeted treatments for chemical injury where no approved antidotes currently exist. Conclusion/future plan: Altogether, this review confirms that phosgene oxime (CX) triggers rapid mast cell activation, causing more severe and immediate inflammation than other vesicants through histamine and cytokine release. Targeting the BTK and SYK signaling pathways, primary mediators of this vascular and immune damage, presents a viable therapeutic strategy where no approved countermeasures currently exist. By inhibiting this neuroimmune response, treatment can effectively reduce acute tissue destruction. Consequently, future research should focus on testing these inhibitors in living models to find the most effective way to treat CX exposure.

Keywords

Natural Science - Biology

Citation

References

Reference metadata is pending and must be finalized before DOI deposit.